Skip to main content
. 2020 Feb 14;111(4):835–844. doi: 10.1093/ajcn/nqaa016

TABLE 1.

Baseline participant characteristics according to diabetes status and baseline scores of metabolites1

By diabetes incidence during follow-up By extreme quartiles of the baseline metabolite score
Subcohort2 Incident cases Quartile 1 Quartile 4
n 691 251 204 252
Age, y 66.5 ± 5.7 66.4 ± 5.7 65.7 ± 5.4 66.8 ± 5.7
Women 62.8 55.0 59.8 60.3
Intervention group
 MedDiet + EVOO 30.4 29.9 33.3 27.0
 MedDiet + nuts 37.3 33.9 39.7 32.1
 Control 32.3 36.3 27.0 40.9
Hypertension 90.9 96.0 90.2 94.4
Dyslipidemia 85.0 79.7 84.3 85.7
Smoking
 Never 60.9 52.6 55.9 57.5
 Former 22.6 22.3 20.6 18.3
 Current 16.5 25.1 23.5 24.2
Waist circumference, cm 99.5 ± 10.7 103.4 ± 10.0 97.9 ± 11.0 103.3 ± 10.1
BMI, kg/m2 29.9 ± 3.6 30.8 ± 3.3 29.5 ± 3.8 30.8 ± 3.5
Physical activity, METs-min/d 239 ± 238 249 ± 232 257 ± 249 220 ± 231
Education
 Elementary or lower 75.5 76.5 69.1 75.8
 Secondary or higher 24.5 23.5 30.9 24.2
Total energy intake, kcal/d 2277 ± 564 2327 ± 622 2316 ± 593 2268 ± 581
MedDiet score3 8.6 ± 1.9 8.5 ± 1.8 8.8 ± 1.7 8.5 ± 2.2
Fasting glucose, mg/dL 99.6 ± 15.2 117.2 ± 17.6 100.2 ± 15.4 108.4 ± 19.2
1

Values are means ± SDs or percentages unless indicated otherwise. EVOO, extra-virgin olive oil; MedDiet, Mediterranean diet; MET, metabolic equivalent task.

2

Thirty-seven cases are included in the randomly selected subcohort.

3

This score is based on the 14-item PREDIMED screener of adherence to the MedDiet.